Author:
Kocaata Zeki,Wilke Thomas,Fischer Franz,Welte Robert,Einsele Hermann
Funder
GlaxoSmithKline GmbH & Co. KG.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Health Policy,Pharmacology
Reference33 articles.
1. Gerecke C, Fuhrmann S, Strifler S, Schmidt-Hieber M, Einsele H, Knop S. The diagnosis and treatment of multiple myeloma. Deutsches Arzteblatt Int. 2016;113(27–28):470–6. https://doi.org/10.3238/arztebl.2016.0470.
2. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. https://doi.org/10.3322/caac.21492.
3. Robert Koch Institut. Cancer in Germany 2015/2016. 12th edition. Zentrum Für Krebsregisterdaten, vol. 12, no. 1, p. 158, 2015, [Online]. https://www.krebsdaten.de/Krebs/EN/Content/Publications/Cancer_in_Germany/cancer_chapters_2015_2016/cancer_germany_2015_2016.pdf?__blob=publicationFile. Accessed 4 Feb 2020.
4. Gay F, Palumbo A. Management of disease- and treatment-related complications in patients with multiple myeloma. Med Oncol. 2010;27(SUPPL):1. https://doi.org/10.1007/s12032-010-9542-z.
5. Regional differences in the treatment approaches for relapsed multiple myeloma: an IMF study. J Clin Oncol. https://doi.org/10.1200/jco.2012.30.15_suppl.8095. Accessed 4 Feb 2020.
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献